Literature DB >> 15000758

The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia.

Anthony E Kline1, Jaime L Massucci, C Edward Dixon, Ross D Zafonte, Bryan D Bolinger.   

Abstract

We recently reported that the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) attenuated traumatic brain injury (TBI)-induced cognitive deficits and histopathology. However, 8-OH-DPAT also produced mild hypothermia (Hypo), which may have contributed to the benefit. To clarify this issue, we conducted an experiment similar to the previous, but included an 8-OH-DPAT group that was maintained at 37 +/- 0.5 degrees C (normothermia; Normo). Isoflurane-anesthetized rats received either a cortical impact (2.7-mm deformation at 4 m/sec) or sham injury and then were randomly assigned to two saline (Sham/Vehicle, n = 5; Injury/Vehicle, n = 10) or three 8-OH-DPAT (Sham/DPAT, n = 5; Injury/DPAT + Normo, n = 10; Injury/DPAT + Hypo, n = 10) groups. 8-OH-DPAT (0.5 mg/kg) or a comparable volume of saline was administered intraperitoneally 15 min after cortical impact or sham injury. Core temperatures were taken prior to treatment and every 15 min thereafter for 2 h. Function was assessed by established motor and cognitive tasks on post-operative days 1-5 and 14-20, respectively. Hippocampal CA1/CA3 cell survival and cortical lesion volume were quantified at 4 weeks. Both the Injury/DPAT + Normo and Injury/DPAT + Hypo groups exhibited enhanced cognitive performance (spatial acquisition and retention) and reduced histopathology (CA3 cell loss and cortical lesion volume) versus the Injury/ Vehicle group (P < 0.05), but did not differ from one another despite a rapid (15 min), mild (34.4-34.9 degrees C), and transient (~1 h) hypothermic effect in the latter. These data confirm that a single systemic administration of 8-OH-DPAT confers neurological protection after TBI, and demonstrate that the beneficial effect is not mediated by concomitant hypothermia. The mechanisms for the protective effects of 8-OH-DPAT after TBI require further inquiry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000758     DOI: 10.1089/089771504322778631

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  27 in total

1.  Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.

Authors:  Anthony E Kline; Adam S Olsen; Christopher N Sozda; Ann N Hoffman; Jeffrey P Cheng
Journal:  J Neurotrauma       Date:  2012-05-21       Impact factor: 5.269

2.  Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone.

Authors:  Adam S Olsen; Christopher N Sozda; Jeffrey P Cheng; Ann N Hoffman; Anthony E Kline
Journal:  J Neurotrauma       Date:  2012-04-23       Impact factor: 5.269

Review 3.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

4.  Empirical comparison of typical and atypical environmental enrichment paradigms on functional and histological outcome after experimental traumatic brain injury.

Authors:  Christopher N Sozda; Ann N Hoffman; Adam S Olsen; Jeffrey P Cheng; Ross D Zafonte; Anthony E Kline
Journal:  J Neurotrauma       Date:  2010-06       Impact factor: 5.269

5.  Abbreviated environmental enrichment enhances neurobehavioral recovery comparably to continuous exposure after traumatic brain injury.

Authors:  Benjamin Wells de Witt; Kathryn M Ehrenberg; Rose L McAloon; Amanda H Panos; Kaitlyn E Shaw; Priya V Raghavan; Elizabeth R Skidmore; Anthony E Kline
Journal:  Neurorehabil Neural Repair       Date:  2010-12-26       Impact factor: 3.919

6.  The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window.

Authors:  Jeffrey P Cheng; Haris A Aslam; Ann N Hoffman; Ross D Zafonte; Anthony E Kline
Journal:  Neurosci Lett       Date:  2007-02-07       Impact factor: 3.046

7.  Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma.

Authors:  Anthony E Kline; Jaime L Massucci; Roos D Zafonte; C Edward Dixon; Judith R DeFeo; Emily H Rogers
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

8.  Environmental enrichment-mediated functional improvement after experimental traumatic brain injury is contingent on task-specific neurobehavioral experience.

Authors:  Ann N Hoffman; Rebecca R Malena; Brian P Westergom; Pallavi Luthra; Jeffrey P Cheng; Haris A Aslam; Ross D Zafonte; Anthony E Kline
Journal:  Neurosci Lett       Date:  2007-12-04       Impact factor: 3.046

Review 9.  Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.

Authors:  Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

10.  Donepezil is ineffective in promoting motor and cognitive benefits after controlled cortical impact injury in male rats.

Authors:  Kaitlyn E Shaw; Corina O Bondi; Samuel H Light; Lire A Massimino; Rose L McAloon; Christina M Monaco; Anthony E Kline
Journal:  J Neurotrauma       Date:  2013-03-26       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.